Arax Advisory Partners’s Avidity Biosciences RNAM Stock Holding History

Arax Advisory Partners’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-187	Closed	-$13.5K	–	4241
2025 Q4	$13.5K	Buy	187 +103	+123%	+$6.65K	﹤0.01%	2328
2025 Q3	$3.66K	Buy	+84	New	+$3.4K	﹤0.01%	2958
2024 Q4	–	Sell	-88	Closed	-$4.04K	–	2693
2024 Q3	$4.04K	Hold	88	–	–	﹤0.01%	1804
2024 Q2	$3.6K	Buy	+88	New	+$2.52K	﹤0.01%	1733

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Arax Advisory Partners's RNAM Position: Q1 2026 in Review

Arax Advisory Partners sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 187 shares — an estimated $13.5K sold.

Arax Advisory Partners first reported a position in RNAM in Q2 2024 and held it in 4 quarters. The position peaked at $13.5K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Arax Advisory Partners reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Arax Advisory Partners sold 187 Avidity Biosciences shares in Q1 2026, an estimated $13.5K.
Arax Advisory Partners first reported a position in Avidity Biosciences in Q2 2024 and held it in 4 quarters.
Arax Advisory Partners's Avidity Biosciences position peaked at $13.5K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.